Cargando…
Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
PURPOSE: The purpose of this study was to understand patient treatment patterns, outcomes, and healthcare resource use in cases of metastatic and/or locally recurrent, unresectable gastric cancer (MGC) in South Korea. MATERIALS AND METHODS: Thirty physicians reviewed charts of eligible patients to c...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512370/ https://www.ncbi.nlm.nih.gov/pubmed/27618820 http://dx.doi.org/10.4143/crt.2016.001 |
_version_ | 1783250474564059136 |
---|---|
author | Carter, Gebra Cuyun Kaltenboeck, Anna Ivanova, Jasmina Liepa, Astra M. San Roman, Alexandra Koh, Maria Rajan, Narayan Cheng, Rebecca Birnbaum, Howard G. Kim, Jong Seok Bang, Yung-Jue |
author_facet | Carter, Gebra Cuyun Kaltenboeck, Anna Ivanova, Jasmina Liepa, Astra M. San Roman, Alexandra Koh, Maria Rajan, Narayan Cheng, Rebecca Birnbaum, Howard G. Kim, Jong Seok Bang, Yung-Jue |
author_sort | Carter, Gebra Cuyun |
collection | PubMed |
description | PURPOSE: The purpose of this study was to understand patient treatment patterns, outcomes, and healthcare resource use in cases of metastatic and/or locally recurrent, unresectable gastric cancer (MGC) in South Korea. MATERIALS AND METHODS: Thirty physicians reviewed charts of eligible patients to collect de-identified data. Patients must have received platinum/fluoropyrimidine first-line therapy followed by second-line therapy or best supportive care, had no other primary cancer, and not participated in a clinical trial following MGC diagnosis. Data were summarized using descriptive statistics. Kaplan-Meier analysis was used to describe survival. RESULTS: Of 198 patients, 73.7% were male, 78.3% were diagnosed with MGC after age 55 (mean, 61.3 years), and 47.0% were current or former smokers. The majority of tumorswere located in the antrum/pylorus (51.5%). Metastatic sites most often occurred in the peritoneum (53.5%), lymph nodes (47.5%), and liver (38.9%). At diagnosis, the mean Charlson comorbidity indexwas 0.4 (standard deviation, 0.6). The most common comorbidities were chronic gastritis (22.7%) and cardiovascular disease (18.7%). Most patients (80.3%) received second-line treatment. Single-agent fluoropyrimidine was reported for 22.0% of patients, while 19.5% were treated with irinotecan and a fluoropyrimidine or platinum agent. The most common physician-reported symptoms during second-line treatment were nausea/vomiting (44.7%) and pain (11.3%), with antiemetics (44.7%), analgesics (36.5%), and nutritional support (11.3%) most often used as supportive care. Two-thirds of inpatient hospitalizations were for chemotherapy infusion. Outpatient hospitalization (31.6%) and visits to the oncologist (58.8%) were common among second-line patients. CONCLUSION: Most patients received second-line treatment, although regimens varied. Understanding MGC patient characteristics and treatment patterns in South Korea will help address unmet needs. |
format | Online Article Text |
id | pubmed-5512370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Korean Cancer Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-55123702017-08-11 Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea Carter, Gebra Cuyun Kaltenboeck, Anna Ivanova, Jasmina Liepa, Astra M. San Roman, Alexandra Koh, Maria Rajan, Narayan Cheng, Rebecca Birnbaum, Howard G. Kim, Jong Seok Bang, Yung-Jue Cancer Res Treat Original Article PURPOSE: The purpose of this study was to understand patient treatment patterns, outcomes, and healthcare resource use in cases of metastatic and/or locally recurrent, unresectable gastric cancer (MGC) in South Korea. MATERIALS AND METHODS: Thirty physicians reviewed charts of eligible patients to collect de-identified data. Patients must have received platinum/fluoropyrimidine first-line therapy followed by second-line therapy or best supportive care, had no other primary cancer, and not participated in a clinical trial following MGC diagnosis. Data were summarized using descriptive statistics. Kaplan-Meier analysis was used to describe survival. RESULTS: Of 198 patients, 73.7% were male, 78.3% were diagnosed with MGC after age 55 (mean, 61.3 years), and 47.0% were current or former smokers. The majority of tumorswere located in the antrum/pylorus (51.5%). Metastatic sites most often occurred in the peritoneum (53.5%), lymph nodes (47.5%), and liver (38.9%). At diagnosis, the mean Charlson comorbidity indexwas 0.4 (standard deviation, 0.6). The most common comorbidities were chronic gastritis (22.7%) and cardiovascular disease (18.7%). Most patients (80.3%) received second-line treatment. Single-agent fluoropyrimidine was reported for 22.0% of patients, while 19.5% were treated with irinotecan and a fluoropyrimidine or platinum agent. The most common physician-reported symptoms during second-line treatment were nausea/vomiting (44.7%) and pain (11.3%), with antiemetics (44.7%), analgesics (36.5%), and nutritional support (11.3%) most often used as supportive care. Two-thirds of inpatient hospitalizations were for chemotherapy infusion. Outpatient hospitalization (31.6%) and visits to the oncologist (58.8%) were common among second-line patients. CONCLUSION: Most patients received second-line treatment, although regimens varied. Understanding MGC patient characteristics and treatment patterns in South Korea will help address unmet needs. Korean Cancer Association 2017-07 2016-09-12 /pmc/articles/PMC5512370/ /pubmed/27618820 http://dx.doi.org/10.4143/crt.2016.001 Text en Copyright © 2017 by the Korean Cancer Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Carter, Gebra Cuyun Kaltenboeck, Anna Ivanova, Jasmina Liepa, Astra M. San Roman, Alexandra Koh, Maria Rajan, Narayan Cheng, Rebecca Birnbaum, Howard G. Kim, Jong Seok Bang, Yung-Jue Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea |
title | Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea |
title_full | Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea |
title_fullStr | Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea |
title_full_unstemmed | Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea |
title_short | Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea |
title_sort | real-world treatment patterns among patients with advanced gastric cancer in south korea |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512370/ https://www.ncbi.nlm.nih.gov/pubmed/27618820 http://dx.doi.org/10.4143/crt.2016.001 |
work_keys_str_mv | AT cartergebracuyun realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT kaltenboeckanna realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT ivanovajasmina realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT liepaastram realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT sanromanalexandra realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT kohmaria realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT rajannarayan realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT chengrebecca realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT birnbaumhowardg realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT kimjongseok realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea AT bangyungjue realworldtreatmentpatternsamongpatientswithadvancedgastriccancerinsouthkorea |